Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$61.89 - $69.28 $44,251 - $49,535
-715 Reduced 3.95%
17,377 $1.17 Million
Q3 2023

Nov 03, 2023

SELL
$64.85 - $71.7 $7,846 - $8,675
-121 Reduced 0.66%
18,092 $1.23 Million
Q2 2023

Aug 08, 2023

BUY
$69.91 - $75.81 $59,563 - $64,590
852 Added 4.91%
18,213 $1.3 Million
Q1 2023

May 08, 2023

BUY
$63.15 - $71.6 $4,231 - $4,797
67 Added 0.39%
17,361 $1.21 Million
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $2,222 - $2,888
41 Added 0.24%
17,294 $1.17 Million
Q3 2022

Oct 28, 2022

SELL
$53.02 - $135.75 $26,881 - $68,825
-507 Reduced 2.85%
17,253 $946,000
Q2 2022

Jul 29, 2022

BUY
$59.26 - $71.14 $11,496 - $13,801
194 Added 1.1%
17,760 $1.17 Million
Q1 2022

Apr 29, 2022

BUY
$55.72 - $67.12 $53,881 - $64,905
967 Added 5.83%
17,566 $1.17 Million
Q4 2021

Jan 28, 2022

BUY
$54.02 - $63.83 $5,131 - $6,063
95 Added 0.58%
16,599 $967,000
Q3 2021

Nov 02, 2021

BUY
$55.56 - $60.79 $14,612 - $15,987
263 Added 1.62%
16,504 $991,000
Q2 2021

Aug 10, 2021

BUY
$48.42 - $60.18 $59,847 - $74,382
1,236 Added 8.24%
16,241 $973,000
Q1 2021

Apr 29, 2021

BUY
$47.16 - $54.44 $130,538 - $150,689
2,768 Added 22.62%
15,005 $746,000
Q4 2020

Feb 08, 2021

SELL
$48.52 - $58.02 $488,499 - $584,145
-10,068 Reduced 45.14%
12,237 $612,000
Q3 2020

Nov 10, 2020

SELL
$53.07 - $61.1 $11,993 - $13,808
-226 Reduced 1.0%
22,305 $1.22 Million
Q2 2020

Jul 29, 2020

SELL
$43.1 - $55.31 $95,337 - $122,345
-2,212 Reduced 8.94%
22,531 $1.19 Million
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $91,338 - $124,064
2,417 Added 10.83%
24,743 $1.11 Million
Q4 2019

Feb 07, 2020

SELL
$42.46 - $50.46 $13,587 - $16,147
-320 Reduced 1.41%
22,326 $1.11 Million
Q3 2019

Nov 07, 2019

BUY
$40.12 - $45.47 $126,498 - $143,366
3,153 Added 16.18%
22,646 $1.01 Million
Q2 2019

Jul 24, 2019

BUY
$37.28 - $41.68 $11,929 - $13,337
320 Added 1.67%
19,493 $805,000
Q1 2019

May 02, 2019

SELL
$35.49 - $43.02 $41,807 - $50,677
-1,178 Reduced 5.79%
19,173 $775,000
Q4 2018

Feb 08, 2019

SELL
$36.86 - $41.49 $884 - $995
-24 Reduced 0.12%
20,351 $773,000
Q3 2018

Nov 08, 2018

BUY
$34.76 - $39.72 $116,550 - $133,181
3,353 Added 19.7%
20,375 $806,000
Q2 2018

Aug 10, 2018

BUY
$34.55 - $37.05 $135,401 - $145,198
3,919 Added 29.91%
17,022 $598,000
Q1 2018

May 04, 2018

BUY
$32.97 - $36.63 $168,245 - $186,922
5,103 Added 63.79%
13,103 $458,000
Q4 2017

Feb 13, 2018

BUY
$32.09 - $34.78 $57,120 - $61,908
1,780 Added 28.62%
8,000 $278,000
Q3 2017

Oct 31, 2017

BUY
$28.96 - $34.0 $180,131 - $211,480
6,220
6,220 $211,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Mitchell Capital Management CO Portfolio

Follow Mitchell Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Capital Management CO with notifications on news.